MARKET

APM

APM

Aptorum Group Ltd
NASDAQ
0.9800
-0.0600
-5.77%
Closed 18:38 05/15 EDT
OPEN
0.9506
PREV CLOSE
1.040
HIGH
1.004
LOW
0.9191
VOLUME
28.38K
TURNOVER
0
52 WEEK HIGH
7.49
52 WEEK LOW
0.4600
MARKET CAP
7.00M
P/E (TTM)
-1.2522
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at APM last week (0505-0509)?
Weekly Report · 3d ago
Weekly Report: what happened at APM last week (0428-0502)?
Weekly Report · 05/05 10:47
Weekly Report: what happened at APM last week (0421-0425)?
Weekly Report · 04/28 10:54
Weekly Report: what happened at APM last week (0414-0418)?
Weekly Report · 04/21 10:54
Aptorum Group Faces Nasdaq Bid Price Compliance Challenge
TipRanks · 04/16 20:29
Aptorum Group receives Nasdaq non-compliance notification
TipRanks · 04/16 16:35
Aptorum Group Receives Notification From Nasdaq Regarding Non-Compliance With Minimum Bid Price Requirement Of $1/Shr
Benzinga · 04/16 16:32
APTORUM GROUP LTD - CONSIDERING REVERSE STOCK SPLIT TO RESTORE COMPLIANCE
Reuters · 04/16 16:27
More
About APM
Aptorum Group Limited is a United Kingdom-based clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The Company's pipeline is also enriched through the co-development of PathsDx Test, a novel molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, commercialization arm of the Singapore's Agency for Science, Technology and Research.

Webull offers Aptorum Group Ltd stock information, including NASDAQ: APM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APM stock methods without spending real money on the virtual paper trading platform.